Published online before print July 28, 2005, doi: 10.1161/01.ATV.0000179676.41064.d4
© 2005 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Cytosolic Lipid Droplets Increase in Size by Microtubule-Dependent Complex Formation
From the Wallenberg Laboratory for Cardiovascular Research (P.B., M.R., J.E., L.A., J.B., S.-O.O.), Göteborg University, Sahlgrenska University Hospital and Holmdahl Biotech (P.H.), Göteborg, Sweden; and the Department of Pharmacological Science and the Center for Developmental Genetics (M.A.F.), Stony Brook University, Stony Brook, NY.
Correspondence to Sven-Olof Olofsson, Wallenberg Laboratory, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. E-mail Sven-Olof.Olofsson{at}wlab.gu.se
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Objectives— Adipocyte differentiation-related protein (ADRP)-containing lipid droplets have an essential role in the development of insulin resistance and atherosclerosis. Such droplets form in a cell-free system with a diameter of 0.1 to 0.4 µm, while the droplets present in cells vary in size, from small to very large, suggesting that the droplets can increase in size after being assembled. We have addressed this possibility.
Methods and Results— Experiments in NIH 3T3 cells demonstrated that the lipid droplets could increase in size independently of triglyceride biosynthesis. NIH 3T3 cells were either microinjected with ADRP–GFP (green fluorescent protein) or stained with Nile Red and followed by confocal microscopy and time-lapse recordings. The results showed that lipid droplets formed complexes with each other, with a volume equal to the sum of the merging particles. The formation of complexes could be inhibited by the nocodazole-induced depolymerization of the microtubules; thus, the process is dependent on microtubules. The presence of dynein on ADRP-containing droplets supports a role for this motor protein.
Conclusions— Lipid droplets can grow after they have been assembled. This increase in size is independent of triglyceride biosynthesis and involves formation of complexes, which requires intact microtubules.
Lipid droplets increase in size by a triglyceride biosynthesis–independent process after their assembly. Confocal microscopy and time-lapse recordings of 3T3 NIH cells, microinjected with ADRP–GFP or stained with Nile Red, indicated that complex formation between droplets could explain this increase in size. This process is dependent on intact microtubules.
Key Words: lipid droplets • lipid droplet fusion • adipocyte differentiation protein • microtubules
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Cytosolic lipid droplets are organelles involved in the storage and turnover of triglycerides and cholesterol esters. Excessive accumulation of triglycerides, particularly in the liver and skeletal muscle, is associated with metabolic disorders such as insulin resistance and type 2 diabetes,1,2 with a strongly increased risk of cardiovascular diseases. Moreover, the accumulation of lipid droplets in macrophages is a key feature of both early and late stages of the atherosclerotic lesion.3 The PAT domain protein4,5 ADRP (adipocyte differentiation-related protein) both promotes the formation of lipid droplets6 (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005) and is an important constituent of the lipid droplets formed in liver, muscles,8 and macrophages.9 Thus, ADRP-containing lipid droplets are important in the pathogenesis of these diseases. In addition, lipid droplets have been proposed to have a central role in the inflammatory response,10 which may further link the structures to the development of both insulin resistance and atherosclerosis.11
Phospholipase D (PLD), which catalyzes the conversion of phosphatidylcholine to phosphatidic acid, promotes the assembly of ADRP-containing lipid droplets from intracellular membranes12 (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005). The newly formed ("primordial") droplets have a diameter of 0.1 to 0.4 µm,12 whereas the mature droplets present in a cell can be more than 10 to 50x larger (even larger in adipocytes) and vary considerable in size, indicating that the primordial lipid droplets increase in size after being formed. This increase appears to be an important step in the process leading to the accumulation of cytosolic lipid droplets in the cell.
In this article we have investigated the assembly of cytosolic lipid droplets, focusing on the mechanism by which they increase in size. We demonstrate that lipid droplets can grow in size by a process that is independent of triglyceride biosynthesis and involves the formation of complexes between the droplets.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
For detailed Materials and Methods, please see the supplemental information available online at http://atvb.ahajournals.org.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Newly Assembled ADRP-Containing Lipid Droplets Can Increase in Size
In the cell-free system,12 the newly formed lipid droplets were 0.1 to 0.4 µm in diameter. In NIH 3T3 cells, the smallest droplets observed after Oil Red O staining were 0.35 µm in diameter. However, when these cells were incubated with oleic acid for increasing periods, the smallest droplets decreased in number, and larger droplets (>3 µm in diameter) formed (Figure 1A). To test the possibility that lipid droplets grow in size after being assembled, NIH 3T3 cells were pulsed with oleic acid for 2 hours and chased for 2 hours in the presence of 20 µmol/L triacsin C, a potent inhibitor of the triglyceride biosynthesis. Under these conditions, insignificant amounts of radiolabeled fatty acids were incorporated into triglycerides (Figure I, available online at http://atvb.ahajournals.org). After the pulse, the greatest proportion of lipid droplets were of small size (< 3 µm) (Fraction I in Figure 1B and 1C). When the cells were chased in the presence of triacsin C, there was a significant decrease in the proportion of droplets present in Fraction I (Figure 1B and 1C, Chase), with a compensatory increase in larger particles present in Fraction II (Figure 1B and 1C, Fraction II). The total area of Oil Red O–stained lipid droplets per cell did not change during the chase. These results indicate that the assembled droplets can increase in size independently of triglyceride biosynthesis.
|
Imaging experiments with live NIH 3T3 cells after incubation with oleic acid showed that the droplets can form complexes with each other. This complex formation was observed in >20 experiments. The formation of typical complexes is shown in detail in two-dimensional (2D) images and in 3D reconstructions (Figures 2 and 3
; Movies I through X, available online at http://atvb.ahajournals.org).
|
|
In Figure 2A, NIH 3T3 cells were microinjected with ADRP-GFP. After 2 hours, the fluorescent protein was associated with discrete droplets. The cells were then followed by time-lapse photography at 30-second intervals. The results show two events marked with blue-yellow and green-red arrows in Figure 2. The blue-yellow arrows show how a droplet moves toward the center of the cell, changes direction, and adheres to another droplet (Figure 2; see also Movie I). The close-up of the event (Figure IIA and Movie II, available online at http://atvb.ahajournals.org) as well as the 3D reconstruction (Figure IIB and Movie III) verifies the adhesion of the two droplets, but they did not form a complex with one fluorescent center during the time investigated.
The green-red arrows show an event in which a smaller droplet (Figure 2A, green arrow) moves toward the center of the cell to be adsorbed on the surface of a larger droplet (Figure 2A, red arrow) and disappears (see also Movie I). Figure 2B shows a close-up of the event (see also Movie IV). The 3D reconstruction (Figure 2C; Movie V) shows that the small droplet did not disappear behind the larger one, but instead interacted with it and was absorbed by it. Thus, the two droplets were replaced by one.
In the second experiment (Figure 3A), the neutral lipids in the cytosolic lipid droplets were stained with Nile Red and the cells were followed by time-lapse photography at 30-second intervals. The green and red arrows point to 2 closely localized droplets that are eventually replaced by a complex with one fluorescent center (Figure 3A; Movie VI). A close-up of the event is shown in Figure 3B and 3C. The 2 droplets adhered to each other (Figure 3B, recording 5) and were replaced by 1 droplet with a homogenous distribution of fluorescence (Figure 3B, recordings 7 to 9; Movie VII). The 3D reconstruction (Figure 3C; Movie VIII) shows that 1 droplet did not simply disappear under the other into a different confocal plain. Instead, the 2 droplets interacted (Figure 3C, recording 4); they clearly adhered to each other (Figure 3C, recordings 5 and 6) and were connected by a "waist-like" structure that disappeared when the 2 droplets were replaced by a single droplet (Figure 3C, recording 7).
The complexity of the complex-forming process is illustrated in Figure III (available online at http://atvb.ahajournals.org) showing a close-up of an event in cells microinjected with ADRP–GFP (time lapse started after 2 hours in culture). The 2D images (Figure IIIA and Movie IX) show one pair of droplets (2 centers of fluorescence and a clear border between the 2 droplets), which adhered to a third droplet (Figure IIIA, recordings 2 to 4), and all droplets were replaced by 1 droplet with homogenous fluorescence (Figure IIIA). The 3D reconstructions (Figure IIIB and Movie X) showed that 1 droplet adhered to the other (and did not simply drop out of the confocal plane), again resulting in the formation of a waist-like structure (Figure IIIB, recordings 2 and 3) that disappeared when a single larger droplet formed (Figure IIIB, recordings 5 to 10).
The volume of the droplets formed was almost identical to the expected volume (the sum of the volumes of the starting droplets). The difference was 6±19% (n=20 formed complexes) of the expected volume.
The Formation of Lipid Droplet Complexes Is Microtubule-Dependent
To begin to investigate the mechanism behind the formation of the complexes, we investigated whether the microtubule system is involved. The cells were incubated with oleic acid for 2 hours and chased for 0 or 2 hours in the presence of triacsin C with and without nocodazole, which at 2 µg/mL destroyed microtubules (Figure 4A). In the absence of nocodazole, the proportion of lipid droplets within Fraction I decreased (Figure 4B; compare with Figure 1B and 1C), and there was a compensatory increase in larger particles (Fraction II; Figure 4B; compare with Figure 1B and 1C). In the presence of nocodazole, however, the particle distribution was unchanged (Figure 4B and 4C). Cells chased in the presence of triacsin C differed from those chased in the presence of both triacsin C and nocodazole as to the recovery of both smaller (Fraction I, P=0.012; t test) and larger (Fraction II, P=0.010; t test) droplets (compare Figures 1C and 4C). The total area of Oil Red O–stained droplets per cell did not change when the cells were chased. Thus, disruption of the microtubule system inhibited the growth of formed cytosolic lipid droplets.
|
We also carried out time-lapse studies after microinjection of ADRP–GFP or after staining of the cells with Nile Red and let the computer identify all fusions that occurred over 5 minutes. Treatment with nocodazole reduced formation of complexes by 88±5% (n=3) in the Nile Red–treated cells. The corresponding mean decrease in 2 ADRP–GFP experiments was 67%. Thus, nocodazole inhibited the formation of complexes between lipid droplets, indicating that both this process and the growth of lipid droplets are dependent on the microtubule system.
Next, we examined ADRP-containing droplets for the motor protein dynein. Cells were transfected with ADRP-GFP, and the chimeric protein was isolated by immunoprecipitation in the absence of detergents (to preserve droplet structure). As shown by immunoblotting, ADRP coprecipitated with dynein (Figure 4D), suggesting that the ADRP-containing droplets could be transported on microtubules by this motor protein.
Finally, we assessed the effect of vanadate, which blocks ATPase activity among that of dynein, on the assembly and fusion of lipid droplets in NIH 3T3 cells. Vanadate reduced the amount of Oil Red O–stained lipid droplets, supporting the possibility that the interaction between motor proteins and microtubules has a central role in the formation of the droplets (Figure 4E). In the experiment shown in Figure 4F, NIH 3T3 cells were incubated with oleic acid in the presence of triacsin C (to prevent the biosynthesis of triglycerides; compare with Figure 4B) and in the absence or presence of vanadate, and the sizes of the lipid droplets were measured. The results indicate that vanadate prevented the increase in size of the droplets.
To study the adhesion process in greater depth, we established a cell-free system. NIH 3T3 cells in separate dishes were transfected with ADRP–GFP or incubated with [3H]-palmitic acid to label triglycerides. Homogenates from both dishes were then coincubated and immunoprecipitated with antibodies to GFP using Dynabeads, and labeled triglycerides were recovered. ADRP–GFP precipitated 
30% of the [3H]-labeled triglycerides from the second cell homogenate; nonspecific binding (to a nonimmune Ig) was 6% (Figure 5A). This indicates that droplets from ADRP-GFP–labeled cells had formed complexes with droplets from [3H]-labeled cells. When the incubation was carried out in the presence of 1 mmol/L calcium, 63% of the radioactivity could be precipitated with the GFP antibody, but nonspecific precipitation was unchanged (Figure 5A). Thus, complex formation was calcium-dependent. There was also an increase in the amount of immunoprecipitable radiolabeled triglycerides when the cell-free system was treated with Mg2+; however, the increase was twice as high when Ca2+ was used. This points to a specific effect of Ca2+.
|
P<0.001 vs Ca 2++nonimmune Ig; 1-way ANOVA. B, The same experiment as in A, but the cell culture transfected with ADRP–GFP was also incubated with [14C]-palmitic acid, wheras the other cell-culture dish was labeled with [3H]-palmitic acid. The anti-GFP precipitate was analyzed for the recovery of [14C]- and [3H]-labeled triglycerides. (mean±SD, n=4). *P<0.001 vs nonimmune IG [14C]; 
P=0.063 vs anti-GFP [3H]. One-way ANOVA). C, Experiment as in A in the absence (control) or presence of Ca2+ and nocodazole as indicated. Results are expressed as recovery of [3H]-triglycerides after immunoprecipitation with antibodies to GFP. Values are mean±SD (Control, n=4; 1 mmol/L Ca2+, n=7; 1 mmol/L Ca2++nocodazole, n=4). *P=0.018 vs control, To verify that ADRP–GFP complexed with the droplets from the second cell homogenate carried triglycerides, we performed double labeling experiments (Figure 5B). Cells in the first dish were transfected with ADRP–GFP and labeled with [14C]-palmitic acid; cells in the second dish were labeled with [3H]-palmitic acid. Both [3H]-labeled and [14C]-labeled triglycerides were recovered after immunoprecipitation of ADRP-GFP, indicating that triglyceride-containing structures had formed complexes with each other. Recovery of [14C]-labeled triglycerides tended to be higher, probably because the GFP antibody also precipitated noncomplexed droplets (ie, those containing only [14C]-labeled triglycerides).
Next, we addressed the importance of microtubules and motor proteins in the cell-free system. Incubation of cell homogenates in the presence of nocodazole completely inhibited complex formation (Figure 5C; compare with the nonspecific binding in Figure 5A). To investigate whether the cell-free system contained organized microtubules, we analyzed the tubulin in the homogenate by immunofluorescence. The results (Figure 5D) demonstrated the presence of polymerized microtubules. Treatment of the system with nocodazole depolymerized the microtubules (Figure 5E). These results clearly demonstrated that intact microtubules were essential for the merging of droplets in the cell-free system.
To determine whether microtubules were important for complex formation or for keeping the complex together, we investigated the effect of conditions that depolymerized microtubules before and during the immunoprecipitation (ie, after the incubation). Decreasing the temperature to 4°C, which rapidly depolymerizes microtubules, failed to influence the recovery of the droplet complex; the ratio between complexes isolated by immunoprecipitation at 4°C and under control conditions was 0.90±0.18 (n=6). Immunofluorescence verified that the microtubules had been depolymerized by the +4° treatment (not shown). Addition of nocodazole after the incubation but before the immunoprecipitation yielded a similar ratio between treated and control cells (0.93±0.26; n=3). These results, together with the observation that the complex formation was completely inhibited when nocodazole was added during the incubation, indicate that microtubules participate in the formation, but not in the stabilization, of the lipid droplet complexes.
Next, we assessed the effect of calcium and vanadate on the interaction between droplets and microtubules in the cell-free system. Ca2+ (1 mmol/L) increased the amount of dynein that coprecipitated with ADRP (Figure 5F), suggesting that the calcium dependence reflects the importance of the interaction between lipid droplets and microtubules. Vanadate (10 µmol/L, with 1 mmol/L Ca2+) reduced the recovery of labeled triglycerides during the immunoprecipitation from 64.5±10.5% (n=11) to 44.6±13.4% (n=3; P<0.017, t test), indicating decreased formation of lipid droplet complexes.
The Rate of Complex Formation
To assess the quantitative importance of the formation of lipid droplet complexes, we used the computer program to identify all complexes that were formed in four 5-minute time-lapse experiments and that met the following criteria: (1) the volume of the droplet formed was at least equal to, but did not exceed by more than 50%, the sum of the volumes of the two substrate droplets; (2) the substrate droplets were clearly identifiable and not more than 3.5 µm apart at time points before the complex formation; and (3) the droplet formed was present at the next time point and had not changed in volume. All formation of complexes identified by the program was confirmed manually by analysis of 2D and 3D images.
The formation of complexes was more frequent when the droplets were smaller and more abundant and became less frequent as the droplets become larger and less abundant (Figure IV, available online at http://atvb.ahajournals.org). Thus, the number of lipid droplets was linearly related to the frequency of complex formation (r=0.76). The sizes of the droplets that formed complexes with each other were not correlated (r=0.24), indicating that droplets of any size can form complexes with each other.
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In this article, we present for the first time results indicating that lipid droplets increase in size by a process that is independent of triglyceride biosynthesis. Time-lapse recordings and confocal microscopy of NIH 3T3 cells microinjected with ADRP–GFP or stained with Nile Red indicated that fusion between the droplets could explain this increase in size. The process is dependent on intact microtubules.
An understanding of the mechanism behind the assembly of cytosolic lipid droplets is of utmost importance for our understanding of the metabolic diseases of the twenty-first century: insulin resistance, type II diabetes, and cardiovascular diseases. The droplets of most direct importance for these diseases are formed in liver, muscles, and macrophages. Such droplets contain the PAT protein4,5 ADRP,8,9 which has a central role in their assembly6 (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005). Accumulation of ADRP-containing lipid droplets in liver and muscle is essential for the development of insulin resistance, one of the major risk-factors in cardiovascular disease.1,2 Moreover, ADRP-containing droplets are present in the lipid-loaded macrophages,9 which are the first sign of atherosclerosis and which become landmarks of the atherosclerotic lesion.3 Indeed, the rate of formation of such ADRP-containing droplets is related to the efflux of lipids from the macrophages,13 because overexpression of ADRP both increases the assembly of the droplets6 (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005) and decreases the cholesterol efflux from the cells, a set of circumstances that may be 1 link between ADRP-containing lipid droplets and atherosclerosis.13 However, there are other links between the accumulation of lipid droplets and metabolic diseases such as the cardiovascular diseases. Thus, the build-up of a store of neutral lipids is part of the lipotoxicicity that has an important role in the development of type II diabetes and the cardiovascular diseases.14–16 Moreover, it is well known that inflammation has a central role in the development of atherosclerosis,11 and it has been demonstrated than inflammation drives the assembly of lipid droplets (see Bandeira-Melo et al10 for review). Thus, an inflammatory stimulus very rapidly increases the amount of droplets in the cell.10 A key role for lipid droplets in the inflammatory response is also suggested by the observation that the enzymes involved in the production of eicosanoids appear to be localized around these droplets.10,17–19 Thus, without any doubt, information on how ADRP-containing lipid droplets are assembled is essential for the understanding of our most important metabolic diseases.
As mentioned, ADRP, which is a fatty acid binding protein,20 has a central role in the assembly of lipid droplets; thus, overexpression of ADRP gives rise to an increase in the formation of droplets6 (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005). However, the mechanism remains to be clarified. We observed that PLD and the production of phosphatidic acid were essential for the assembly of lipid droplets,12 results that were confirmed recently in intact cells (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005). The results from the experiments in intact cells also indicated that part of the effect of PLD1 could be explained by regulation of the intracellular concentration of ADRP (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005). Thus, an increase in PLD1 gives rise to a large increase in ADRP, resulting in increased formation of lipid droplets.
Another key factor in the assembly of lipid droplets, originally found to be a cytosolic activator of lipid droplet assembly,12 was recently identified as extracellular signal regulated kinase (ERK)2 (L.A., P.B., M.R., J.E., Marchesan D, Magnusson B, Ruiz M, P.H., Asp L, M.A.F., J.B., S.-O.O., unpublished data, 2005).
The results from studies in a cell-free system indicated that the newly assembled lipid droplets had a size between 0.1 and 0.4 µm.12 Small droplets were also detected in cells both after subcellular fractionation12 and by microscopy after Oil Red O staining (this study); however, it is well known that the cells also contain much larger droplets, suggesting that the process by which lipid droplets are formed is complex and involves a second step in which the "primordial" droplets can grow in size. In this article, we have demonstrated that such growth can occur without ongoing triglyceride biosynthesis. One reason for this was elucidated by in vivo imaging studies, which demonstrated that 2 droplets could form a complex with each other, giving rise to a larger droplet with homogenous fluorescence. The 3D reconstructions excluded the possibility that 1 droplet simply disappeared from the confocal plane, revealing instead an intermediate waist-like structure that connected the droplets and disappeared when the 2 droplets were replaced by a single droplet. Moreover, the volume of the droplet formed was very close to the sum of the volumes of the substrate droplets. Together, these results indicate that two droplets are replaced by one, ie, they fuse with each other, to form a larger droplet.
Nocodazole inhibited the fusion of the droplets, indicating a dependence on microtubules. In several cases, we observed that lipid droplets are transported toward the center of the cell, suggesting dynein-mediated transport on microtubules. Consistent with this notion, ADRP-containing droplets also contained the motor protein dynein. An involvement of dynein is also supported by the observation that vanadate, which inhibits the ATPase of the motor proteins, prevented the droplets from growing in size. However, when evaluating these results it should be kept in mind that vanadate has a rather unspecific effect. Moreover, in many cases we could not observe an unequivocal central transport of the droplets before the complex was formed. Instead, they seemed to be localized close to each other before they fused. This suggests that the microtubules are not only important for long-distance transport, but also for the process by which the droplets are brought so close together that the fusion machinery can start working. This is supported by the observations in the cell-free system, which verifies the importance of microtubules in the formation of complexes but argues against the idea that they keep the droplets together after the complex has been formed. The importance of microtubules and motor proteins for the transport of cytosolic lipid droplets is in agreement with observations in Drosophila.21
Our results indicate that the fusion process seen in intact cells can be reconstructed in the cell-free system. Such a system will be very useful when evaluating the molecular background to the fusion process. Indeed, the lipid droplets contain proteins that may affect the process through their involvement in sorting processes (the Rab proteins)22,23 and fusion events (
-SNAP).22
The rate of merging events varied, and droplets of any size could form complexes with each other. This makes it difficult to estimate how long it would take for a large droplet to form. A conservative estimate based on our results would suggest that a lipid droplet with a diameter of 4 µm could be assembled in <10 minutes. Thus, the fusion between droplets is a quantitatively important mechanism in the formation of larger lipid droplets.
In summary, lipid droplets can increase in size by a mechanism that does not involve triglyceride biosynthesis but is based of the fusion of the droplets with each other. The process requires microtubules and, most likely, the motor protein dynein.
|
Acknowledgments |
|---|
This study was supported financially by the Swedish Medical Research Council (grant 7142) and by the Swedish Heart and Lung Foundation, Novo Nordic Foundation, Swedish Strategic Funds (National Network and Graduate School for Cardiovascular Research), and the Söderberg Foundation. The imaging was carried out at the Swegene center for cellular imaging in Göteborg. L.A. holds a Swegene postdoctoral position in proteomics.
Received April 21, 2005; accepted July 12, 2005.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004; 114: 147–152.[CrossRef][Medline] [Order article via Infotrieve]
2. den Boer M, Voshol PJ, Kuipers F, Havekes LM, Romijn JA. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol. 2004; 24: 644–649.
3. Stary HC. Lipid and macrophage accumulations in arteries of children and the development of atherosclerosis. Am J Clin Nutr. 2000; 72: 1297S–1306S.
4. Londos C, Brasaemle DL, Schultz CJ, Segrest JP, Kimmel AR. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol. 1999; 10: 51–58.[CrossRef][Medline] [Order article via Infotrieve]
5. Lu X, Gruia-Gray J, Copeland NG, Gilbert DJ, Jenkins NA, Londos C, Kimmel AR. The murine perilipin gene: the lipid droplet-associated perilipins derive from tissue-specific, mRNA splice variants and define a gene family of ancient origin. Mamm Genome. 2001; 12: 741–749.[Medline] [Order article via Infotrieve]
6. Imamura M, Inoguchi T, Ikuyama S, Taniguchi S, Kobayashi K, Nakashima N, Nawata H. ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am J Physiol Endocrinol Metab. 2002; 283: E775–E783.
8. Brasaemle DL, Barber T, Wolins N, Serrero G, Blanchette-Mackie EJ, Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet associated protein. J Lipid Res. 1997; 38: 2249–2263.[Abstract]
9. Chen JS, Greenberg AS, Tseng YZ, Wang SM. Possible involvement of protein kinase C in the induction of adipose differentiation-related protein by Sterol ester in RAW 264.7 macrophages. J Cell Biochem. 2001; 83: 187–199.[CrossRef][Medline] [Order article via Infotrieve]
10. Bandeira-Melo C, Bozza PT, Weller PF. The cellular biology of eosinophil eicosanoid formation and function. J Allergy Clin Immunol. 2002; 109: 393–400.[CrossRef][Medline] [Order article via Infotrieve]
11. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685–1695.
12. Marchesan D, Rutberg M, Andersson L, Asp L, Larsson T, Boren J, Johansson BR, Olofsson SO. A phospholipase D-dependent process forms lipid droplets containing caveolin, adipocyte differentiation-related protein, and vimentin in a cell-free system. J Biol Chem. 2003; 278: 27293–27300.
13. Larigauderie G, Furman C, Jaye M, Lasselin C, Copin C, Fruchart JC, Castro G, Rouis M. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler Thromb Vasc Biol. 2004; 24: 504–510.
14. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002; 53: 319–336.[CrossRef][Medline] [Order article via Infotrieve]
15. Unger RH. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab. 2003; 14: 398–403.[CrossRef][Medline] [Order article via Infotrieve]
16. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003; 144: 5159–5165.
17. Diaz BL, Arm JP. Phospholipase A(2). Prostaglandins Leukot Essent Fatty Acids. 2003; 69: 87–97.[CrossRef][Medline] [Order article via Infotrieve]
18. Bandeira-Melo C, Phoofolo M, Weller PF. Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem. 2001; 276: 22779–22787.
19. Bozza PT, Weller PF. Arachidonyl trifluoromethyl ketone induces lipid body formation in leukocytes. Prostaglandins Leukot Essent Fatty Acids. 2001; 64: 227–230.[CrossRef][Medline] [Order article via Infotrieve]
20. Serrero G, Frolov A, Schroeder F, Tanaka K, Gelhaar L. Adipose differentiation related protein: expression, purification of recombinant protein in Escherichia coli and characterization of its fatty acid binding properties. Biochim Biophys Acta. 2000; 1488: 245–254.[Medline] [Order article via Infotrieve]
21. Welte MA, Gross SP, Postner M, Block SM, Wieschaus EF. Developmental regulation of vesicle transport in Drosophila embryos: forces and kinetics. Cell. 1998; 92: 547–557.[CrossRef][Medline] [Order article via Infotrieve]
22. Liu P, Ying Y, Zhao Y, Mundy DI, Zhu M, Anderson RG. Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J Biol Chem. 2004; 279: 3787–3792.
23. Brasaemle DL, Dolios G, Shapiro L, Wang R. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3–L1 adipocytes. J Biol Chem. 2004; 279: 46835–46842.
This article has been cited by other articles:
 |
|
 |
|
  L. Nikonova, R. A. Koza, T. Mendoza, P.-M. Chao, J. P. Curley, and L. P. Kozak Mesoderm-specific transcript is associated with fat mass expansion in response to a positive energy balance FASEB J, November 1, 2008; 22(11): 3925 - 3937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Goodman The Gregarious Lipid Droplet J. Biol. Chem., October 17, 2008; 283(42): 28005 - 28009. [Full Text] [PDF]
|
|
|
|
|
|
A. Gubern, J. Casas, M. Barcelo-Torns, D. Barneda, X. de la Rosa, R. Masgrau, F. Picatoste, J. Balsinde, M. A. Balboa, and E. Claro Group IVA Phospholipase A2 Is Necessary for the Biogenesis of Lipid Droplets J. Biol. Chem., October 10, 2008; 283(41): 27369 - 27382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Imanishi, W. Sun, T. Maeda, A. Maeda, and K. Palczewski Retinyl Ester Homeostasis in the Adipose Differentiation-related Protein-deficient Retina J. Biol. Chem., September 5, 2008; 283(36): 25091 - 25102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Ducharme and P. E. Bickel Minireview: Lipid Droplets in Lipogenesis and Lipolysis Endocrinology, March 1, 2008; 149(3): 942 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Fei, G. Shui, B. Gaeta, X. Du, L. Kuerschner, P. Li, A. J. Brown, M. R. Wenk, R. G. Parton, and H. Yang Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast J. Cell Biol., February 6, 2008; 180(3): 473 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacheco, A. Vieira-de-Abreu, R. N. Gomes, G. Barbosa-Lima, L. B. Wermelinger, C. M. Maya-Monteiro, A. R. Silva, M. T. Bozza, H. C. Castro-Faria-Neto, C. Bandeira-Melo, et al. Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 Controls Microtubule-Driven Biogenesis and Leukotriene B4-Synthesizing Function of Macrophage Lipid Bodies Elicited by Innate Immune Response J. Immunol., December 15, 2007; 179(12): 8500 - 8508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Kim, Y. Wu, and C. M. Smas Characterization of ScAP-23, a new cell line from murine subcutaneous adipose tissue, identifies genes for the molecular definition of preadipocytes Physiol Genomics, October 19, 2007; 31(2): 328 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Magnusson, L. Asp, P. Bostrom, M. Ruiz, P. Stillemark-Billton, D. Linden, J. Boren, and S.-O. Olofsson Adipocyte Differentiation-Related Protein Promotes Fatty Acid Storage in Cytosolic Triglycerides and Inhibits Secretion of Very Low-Density Lipoproteins Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1566 - 1571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Andersson, P. Bostrom, J. Ericson, M. Rutberg, B. Magnusson, D. Marchesan, M. Ruiz, L. Asp, P. Huang, M. A. Frohman, et al. PLD1 and ERK2 regulate cytosolic lipid droplet formation J. Cell Sci., June 1, 2006; 119(11): 2246 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li, P. Stillemark-Billton, C. Beck, P. Bostrom, L. Andersson, M. Rutberg, J. Ericsson, B. Magnusson, D. Marchesan, A. Ljungberg, et al. Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL J. Lipid Res., January 1, 2006; 47(1): 67 - 77. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||